Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
2623.0000 -6.55 (-0.25%)
NSE Mar 28, 2025 15:53 PM
Volume: 120.5K
 

logo
Ajanta Pharma Ltd.
03 Nov 2018
2623.00
-0.25%
buy
Results Update: Ajanta Pharma Ltd.
by HDFC Securities
HDFC Securities
Ajanta Pharma Ltd Q2FY19 results Comment Revenue increased by 6.48% to Rs. 544.11 Cr in Q2FY19 when compared to the previous quarter. Also, it rose by 0.69% when compared with Q2FY18
 
Ajanta Pharma Ltd. is trading above its 30 day SMA of 2600.5
More from Ajanta Pharma Ltd.
Recommended
Market closes lower, Jio Fin Serv invests Rs 1,000.2 crore in its subsidiary Jio Finance
Trendlyne Marketwatch | 28 Mar 2025, 04:05PM
Chart of the Week: Most new-age IT IPOs drop in valuations post listing
The Baseline | 27 Mar 2025, 04:19PM
Ajanta Pharma disputes ET article on FDA import alert
| 24 Jan 2017